IDEXX LABORATORIES INC /DE — Director's Dealing 2021

Aug 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2021-08-05

Reporting Person: Hunt Nimrata (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-05	Common Stock	M	27	$67.85	Acquired	8133.2845	Direct
2021-08-05	Common Stock	M	511	$141.60	Acquired	8644.2845	Direct
2021-08-05	Common Stock	S	538	$703	Disposed	8106.2845	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-05	Non-Qualified Stock Option (right-to-buy)	$67.85	M	27	Disposed	2026-02-13	Common Stock (27)	Direct
2021-08-05	Non-Qualified Stock Option (right-to-buy)	$141.60	M	511	Disposed	2027-02-13	Common Stock (511)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	160	Indirect

Footnotes

F1: Includes a total of 23.2845 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2021 and June 30, 2021.

F2: Grant of option to buy 1,940 shares of Issuer common stock that vested in five annual installments beginning on February 14, 2017.

F3: Grant of option to buy 3,579 shares of Issuer common stock that vest in five annual installments beginning on February 14, 2018.

F4: Not applicable.